Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Leqembi Iqlik (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher...
FDA Approves Wayrilz (rilzabrutinib) for Immune Thrombocytopenia
Paris, August 29, 2025 – The US Food and Drug Administration (FDA) has approved Wayrilz (rilzabrutinib) for adults with persistent or chronic...
Pfizer and BioNTech’s Comirnaty Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
(BUSINESS WIRE) August 27, 2025 -- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”)...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration...
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
From 2021 to 2024, 59.0 percent of overdose deaths involved stimulants, according to research published in the Aug. 28 issue of the U.S. Centers for Disease...
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous...
Cannabis-Based Medical Products Aid Primary Insomnia
Insomnia patients taking cannabis-based medicinal products report better quality sleep, according to a study published online Aug. 27 in PLOS Mental...
Sleep Problems Tied to Self-Harm in Teens
Sleep problems in early teens are associated with future self-harm, according to a study published online Aug. 4 in the Journal of Child Psychology...
Women Benefit More From Implantable Defibrillators Than Men
There is a lower risk of one-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator...
Gordon Ramsay Reveals Skin Cancer Diagnosis, Urges Folks To Use Sunscreen
TUESDAY, Sept. 2, 2025 — Celebrity chef and restaurateur Gordon Ramsay revealed he had surgery to remove basal cell carcinoma, a common form of skin...
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift
TUESDAY, Sept. 2, 2025 — CVS and Walgreens are changing where and how they offer COVID-19 vaccines this season as they work to comply with state...
Jim O’Neill Steps in as Acting CDC Chief Amid Firing, Resignations
TUESDAY, Sept. 2, 2025 — The U.S. Centers for Disease Control and Prevention (CDC) is entering a transition period as Jim O’Neill, deputy secretary...
Baxdrostat Demonstrated Statistically Significant and Clinically Meaningful Reduction in Systolic Blood Pressure in Patients with Hard-to-Control Hypertension in the BaxHTN Phase III Trial
Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction...
Common Pain Meds, Acetaminophen and Ibuprofen, Could Be Contributing To Antibiotic Resistance
FRIDAY, Aug. 29, 2025 — Common over-the counter painkillers might be quietly fueling antibiotic resistance, a new study warns. Ibuprofen and acetaminophen...
FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine
FDA Removes Risk Evaluation and Mitigation Strategies (REMS) Program for the Antipsychotic Drug Clozapine Neutropenia Risk Remains, but REMS No Longer...
Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling
August 27, 2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets...
Recently Added
Recently added consumer and prescribing information: mNEXSPIKE, Cyklx, Papzimeos, Brinsupri, Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Wayrilz Wayrilz (rilzabrutinib) is a kinase inhibitor indicated for the treatment of adult patients with persistent or chronic immune...
- Dawnzera Dawnzera (donidalorsen) is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary...
- Tonmya Tonmya (cyclobenzaprine hydrochloride) is a sublingual formulation of cyclobenzaprine hydrochloride indicated for the treatment of...